Search Results - "Ingole, Nayana"

Refine Results
  1. 1

    Comparison of CBNAAT and conventional real time RT PCR for HIV 1 viral load testing by Ingole, Nayana A., Nataraj, Gita

    Published in Indian journal of medical microbiology (01-10-2021)
    “…HIV viral load testing is now recommended for monitoring of anti-retroviral treatment failure in PLHIV. Xpert® HIV-1 Viral Load is a fully automated CB-NAAT. A…”
    Get full text
    Journal Article
  2. 2

    Performance characteristics and operational feasibility assessment of a CRISPR based tata MD CHECK diagnostic test for SARS-CoV-2 (COVID-19) by Shenai, Shubhada, Nataraj, Gita, Jinwal, Minal, Thekke Purakkal, Akhil S, Sen, Rajashree, Ingole, Nayana, Mathure, Trupti, Sarin, Sanjay, Chadha, Sarabjit S

    Published in PloS one (14-09-2023)
    “…Background Tata MD CHECK SARS-CoV-2 kit 1.0, a CRISPR based reverse transcription PCR (TMC-CRISPR) test was approved by Indian Council of Medical Research…”
    Get full text
    Journal Article
  3. 3

    Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India by Laxmeshwar, Chinmay, Acharya, Shrikala, Das, Mrinalini, Keskar, Padmaja, Pazare, Amar, Ingole, Nayana, Mehta, Preeti, Gori, Pooja, Mansoor, Homa, Kalon, Stobdan, Singh, Pramila, Mathur, Taanya, Ferlazzo, Gabriella, Isaakidis, Petros

    Published in PloS one (05-05-2020)
    “…Routine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevalence of Cryptococcaemia in HIV Seropositive Patients in an Indian Setting by Vijay, Swati, Ingole, Nayana, Wanjare, Shashir, Mehta, Preeti

    “…Introduction: Cryptococcal infection is the most common opportunistic fungal infection was seen in HIV patients. Despite specific treatment, mortality due to…”
    Get full text
    Journal Article
  6. 6

    Role of Quality Management System in Setting up and Sustaining a Molecular Diagnostic Laboratory during COVID-19 Pandemic by Nayana Ingole, Trupti Mathure, Meena Jinwal, PL Kashyap, Shreeraj Talwadekar, Gita Nataraj

    Published in National journal of laboratory medicine (01-01-2022)
    “…Introduction: Coronavirus Disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) catapulted the need to build,…”
    Get full text
    Journal Article
  7. 7

    HIV-2 infection: Where are we today? by Ingole, Nayana, Sarkate, Purva, Paranjpe, Supriya, Shinde, Sameer, Lall, Sujata, Mehta, Preeti

    Published in Journal of global infectious diseases (01-07-2013)
    “…Context: The choice of antiretroviral therapy for HIV-2 differs from that for HIV-1, underscoring the importance of differentiating between the two. Aims: The…”
    Get full text
    Journal Article
  8. 8

    CD4 Counts in Laboratory Monitoring of HIV Disease—Experience from Western India by Ingole, Nayana, Nataraj, Gita, Mehta, Preeti, Paranjpe, Supriya, Sarkate, Purva

    “…Background: CD4 counts vary in different populations. The present study was conducted to determine CD4 counts in different World Health Organization (WHO)…”
    Get full text
    Journal Article
  9. 9

    Hepatitis B Virus (HBV) Infection in Liver Disease Patients in Mumbai, India with Special Reference to Hepatitis B Surface Antigen (HBsAg) Mutant Detection by Kamat, Shweta P, Mehta, Preeti R, Paranjpe, Supriya M, Ingole, Nayana A

    “…To determine the prevalence of Hepatitis B Surface antigen (HBsAg) in patients attending the Hepatology Out Patient Department (OPD) of a tertiary care…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Achieving UNAIDS Viral Suppression Goal: Experience from a Tertiary Care Public Hospital, Western India by Thate, Ranjana, Ingole, Nayana, Surase, Vaishali Solanke, Joshi, Kavita, Bajpai, Smrati, Acharya, Shrikala, Nataraj, Gita

    “…Targeted HIV 1 viral load testing has been recommended in 2010 only for suspected cases of antiretroviral therapy failure. India is committed to achieve UNAIDS…”
    Get full text
    Journal Article
  12. 12

    Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients by Dutta, Anuja, Mehta, Preeti, Ingole, Nayana

    “…Background & objectives: Immunocompromised individuals mainly HIV infected patients are at a great risk for developing toxoplasmosis. The presence of…”
    Get full text
    Journal Article
  13. 13

    Performance of immunological response in predicting virological failure by Ingole, Nayana, Mehta, Preeti, Pazare, Amar, Paranjpe, Supriya, Sarkate, Purva

    Published in AIDS research and human retroviruses (01-03-2013)
    “…In HIV-infected individuals on antiretroviral therapy (ART), the decision on when to switch from first-line to second-line therapy is dictated by treatment…”
    Get more information
    Journal Article
  14. 14

    Performance characteristics and operational feasibility assessment of a CRISPR based tata MD CHECK diagnostic test for SARS-CoV-2 (COVID-19) by Shubhada Shenai, Gita Nataraj, Minal Jinwal, Akhil S Thekke Purakkal, Rajashree Sen, Nayana Ingole, Trupti Mathure, Sanjay Sarin, Sarabjit S Chadha

    Published in PloS one (01-01-2023)
    “…BackgroundTata MD CHECK SARS-CoV-2 kit 1.0, a CRISPR based reverse transcription PCR (TMC-CRISPR) test was approved by Indian Council of Medical Research…”
    Get full text
    Journal Article
  15. 15

    Clinical course and outcomes of COVID-19 in kidney transplant recipients by Bajpai, Divya, Deb, Satarupa, Bose, Sreyashi, Gandhi, Chintan, Modi, Tulsi, Katyal, Abhinav, Saxena, Nikhil, Patil, Ankita, Patil, Sunil, Thakare, Sayali, Pajai, Atim, Haridas, Ashwathy, Keskar, Vaibhav, Jawale, Sunil, Sultan, Amar, Nataraj, Gita, Ingole, Nayana, Jamale, Tukaram

    Published in Indian journal of nephrology (01-09-2022)
    “…Introduction: Kidney transplant recipients (KTR) are at increased risk of morbidity and mortality due to coronavirus disease 2019 (COVID-19). This study aimed…”
    Get full text
    Journal Article
  16. 16

    Profiles of HIV-infected anti-retroviral therapy naïve children from Mumbai, India by Paranjpe, Supriya Mayur, Sarkate, Purva Pankaj, Ingole, Nayana Avinash, Raut, Shweta Sadanand, Mehta, Preeti Rajeev

    Published in World journal of pediatrics : WJP (01-11-2016)
    “…Background This study aimed to investigate the demographic profiles of human immunodifficiency virus (HIV) infected anti-retroviral therapy (ART) naïve…”
    Get full text
    Journal Article
  17. 17

    CD4 counts in laboratory monitoring of HIV disease--experience from western India by Ingole, Nayana, Nataraj, Gita, Mehta, Preeti, Paranjpe, Supriya, Sarkate, Purva

    “…CD4 counts vary in different populations. The present study was conducted to determine CD4 counts in different World Health Organization (WHO) clinical stages…”
    Get full text
    Journal Article
  18. 18

    Monitoring HIV Epidemic in Pregnant Women: Are the Current Measures Enough? by Sarkate, Purva, Paranjpe, Supriya, Ingole, Nayana, Mehta, Preeti

    Published in Journal of sexually transmitted diseases (01-01-2015)
    “…Introduction. Burden of HIV in pregnant women follows overall epidemic in India. Hence, it is imperative that prevalence calculations in this group be…”
    Get full text
    Journal Article
  19. 19

    Laboratory tests for malaria: a diagnostic conundrum? by Puri, Balaji, Mehta, Preeti, Ingole, Nayana A, Prasad, Priyanka, Mathure, Trupti

    Published in South African medical journal (01-09-2013)
    “…To detect malarial parasites using the peripheral blood smear (PBS) and to compare the PBS with the immunochromatographic antigen test (i.e. OptiMAL and…”
    Get full text
    Journal Article
  20. 20

    Role of CD4 count estimation in the era of HIV-1 viral load among PLHIV by Thate, Ranjana N., Ingole, Dr Nayana, Solanke-Surase, Vaishali, Joshi, Kavita, Bajpayi, Smrati, Acharya, Shrikala, Nataraj, Gita

    Published in Indian journal of medical microbiology (01-11-2023)
    “…ART has improved the life expectancy of people living with HIV (PLHIV) by suppressing the virus and increasing CD4 count. Some PLHIV shows immune-virological…”
    Get full text
    Journal Article